Yan Vlasov, co-chairman of the All-Russian Union of Public Associations of Patients, has called for increased regulation of oral contraceptives, emphasizing the need for...
The International Association Anti-Counterfeit has launched a project titled «Do Not Take Risks! Check», aimed at creating public registers of safe and unsafe dietary...
Andrey Ivashchenko, Chairman of the Board of Directors of KhimRar Group, Professor of the Russian Academy of Sciences (RAS), noted that there is now...
The R-Pharm Group of Companies and the Siberian State Medical University have signed a partnership agreement for joint research and technology development.
R-Pharm has many...
The volume of drug production in Russia increased by 21.5% in 2024, amounting to about 800 billion rubles, Prime Minister Mikhail Mishustin said during...
Petrovax Pharm and the Gamaleya National Research Center for Epidemiology and Microbiology have signed their cooperation agreement. As the biopharmaceutical company's press service told...
The Russian Ministry of Health has registered Maritupirdin, a new drug for the treatment of anxiety disorders, which is notable for its multi-target activity...
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
